U.S. Markets open in 2 hrs 24 mins

What Analysts Recommend for Boston Scientific, Post-Q2 Results

Sarah Collins
What Analysts Recommend for Boston Scientific, Post-Q2 Results

Boston Scientific (BSX) announced its Q2 2018 results on July 25, exceeding analysts’ estimates. That day, BSX stock rose ~2.2%, while the iShares US Medical Devices ETF (IHI) rose ~1.4%. BSX comprises ~4.7% of IHI.